文献速递血液净化与透析肾移植慢性肾脏病

英国维持性肾脏替代治疗患者合并症校正后死亡率下降趋势

Declining comorbidity-adjusted mortality rates in English patients receiving maintenance renal replacement therapy.
PubMed 文献 · Kidney Int · 2018-02-12

该研究比较了终末期肾病患者与普通人群在年龄、性别和合并症校正后的长期死亡率趋势。

要点

  • 死亡率下降在肾移植和透析患者中均可见,且不受糖尿病状态影响。
  • 忽略合并症变化会低估RRT患者死亡率的实际改善程度。

研究设计与样本

  • 研究基于Oxford Record Linkage Study(1965-1999)和全英格兰Hospital Episode Statistics(2000-2011)两个电子住院数据集。

主要发现

  • RRT起始中位年龄从1970-1990年的49岁增至2006-2008年的61岁,血管疾病患病率从10.0%升至25.2%,糖尿病从6.7%升至33.9%。
  • 校正年龄、性别和合并症后,1970-2011年RRT患者标准化三年全因死亡率相对下降51%(95%CI 41-60%),普通人群下降34%(31-36%)。
  • 死亡率下降在肾移植患者、透析患者以及合并和不合并糖尿病的亚组中均可见。

临床怎么用

  • 评估RRT患者死亡率趋势时需校正合并症变化,否则会低估实际改善幅度。
  • RRT患者死亡率改善速度快于普通人群,提示肾脏替代治疗和综合管理可能带来额外获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We aimed to compare long-term mortality trends in end-stage renal disease versus general population controls after accounting for differences in age, sex and comorbidity. Cohorts of 45,000 patients starting maintenance renal replacement therapy (RRT) and 5.3 million hospital controls were identified from two large electronic hospital inpatient data sets: the Oxford Record Linkage Study (1965-1999) and all-England Hospital Episode Statistics (2000-2011). All-cause and cause-specific three-year mortality rates for both populations were calculated using Poisson regression and standardized to the age, sex, and comorbidity structure of an average 1970-2008 RRT population. The median age at initiation of RRT in 1970-1990 was 49 years, increasing to 61 years by 2006-2008. Over that period, there were increases in the prevalence of vascular disease (from 10.0 to 25.2%) and diabetes (from 6.7 to 33.9%). After accounting for age, sex and comorbidity differences, standardized three-year all-cause mortality rates in treated patients with end-stage renal disease between 1970 and 2011 fell by about one-half (relative decline 51%, 95% confidence interval 41-60%) steeper than the one-third decline (34%, 31-36%) observed in the general population. Declines in three-year mortality rates were evident among those who received a kidney transplant and those who remained on dialysis, and among those with and without diabetes. These data suggest that the full extent of mortality rate declines among RRT patients since 1970 is only apparent when changes in comorbidity over time are taken into account, and that mortality rates in RRT patients appear to have declined faster than in the general population.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Storey BC, Staplin N, Harper CH, et al. Declining comorbidity-adjusted mortality rates in English patients receiving maintenance renal replacement therapy. Kidney Int. 2018. PMID: 29395337. doi:10.1016/j.kint.2017.11.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。